IN2014CN02963A - - Google Patents

Info

Publication number
IN2014CN02963A
IN2014CN02963A IN2963CHN2014A IN2014CN02963A IN 2014CN02963 A IN2014CN02963 A IN 2014CN02963A IN 2963CHN2014 A IN2963CHN2014 A IN 2963CHN2014A IN 2014CN02963 A IN2014CN02963 A IN 2014CN02963A
Authority
IN
India
Prior art keywords
strains
generating
methods
host cells
relates
Prior art date
Application number
Other languages
English (en)
Inventor
Bo Jiang
Rebecca D Argyros
Stephanie Nelson
Robert C Davidson
Ronghua Chen
Jun Zhuang
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of IN2014CN02963A publication Critical patent/IN2014CN02963A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN2963CHN2014 2011-10-28 2012-10-23 IN2014CN02963A (enrdf_load_stackoverflow)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161552674P 2011-10-28 2011-10-28
PCT/US2012/061432 WO2013062940A1 (en) 2011-10-28 2012-10-23 Engineered lower eukaryotic host strains for recombinant protein expression

Publications (1)

Publication Number Publication Date
IN2014CN02963A true IN2014CN02963A (enrdf_load_stackoverflow) 2015-07-03

Family

ID=48168381

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2963CHN2014 IN2014CN02963A (enrdf_load_stackoverflow) 2011-10-28 2012-10-23

Country Status (9)

Country Link
US (1) US9328367B2 (enrdf_load_stackoverflow)
EP (1) EP2771461B1 (enrdf_load_stackoverflow)
JP (1) JP2014532406A (enrdf_load_stackoverflow)
KR (1) KR20140091018A (enrdf_load_stackoverflow)
CN (1) CN104024409A (enrdf_load_stackoverflow)
AU (1) AU2012329091A1 (enrdf_load_stackoverflow)
CA (1) CA2853341A1 (enrdf_load_stackoverflow)
IN (1) IN2014CN02963A (enrdf_load_stackoverflow)
WO (1) WO2013062940A1 (enrdf_load_stackoverflow)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2012DN01920A (enrdf_load_stackoverflow) 2009-09-03 2015-07-24 Schering Corp
WO2013062940A1 (en) 2011-10-28 2013-05-02 Merck Sharp & Dohme Corp. Engineered lower eukaryotic host strains for recombinant protein expression
US9416389B2 (en) * 2012-02-16 2016-08-16 Merck Sharp & Dohme Corp. Methods for reducing mannosyltransferase activity in lower eukaryotes
WO2014066134A1 (en) * 2012-10-22 2014-05-01 Merck Sharp & Dohme Corp. Crz1 mutant fungal cells
ES2881279T3 (es) * 2015-03-03 2021-11-29 Novartis Ag Sistema de expresión basado en promotor de LLP de levadura constitutivo
US20190330601A1 (en) * 2016-05-13 2019-10-31 University Of Copenhagen A cell-based array platform
JP2018038286A (ja) * 2016-09-05 2018-03-15 国立大学法人神戸大学 新規宿主細胞及びそれを用いた目的タンパク質の製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000063667A2 (en) * 1999-04-21 2000-10-26 American Home Products Corporation Methods for identifying modulators of n-type ion channel inactivation
US20060148000A1 (en) * 1999-04-21 2006-07-06 Wyeth Methods for identifying modulators of N-type ion channel inactivation
EP1283870A4 (en) * 2000-04-24 2004-05-12 Wyeth Corp NOVEL CELL SYSTEMS HAVING SPECIFICALLY INTERACTED PEPTIDE BINDING PAIRS
WO2001088143A1 (fr) 2000-05-17 2001-11-22 Mitsubishi Pharma Corporation Procede d'elaboration de proteine avec reduction de chaine saccharose acide, et glycoproteine resultante
US7795002B2 (en) 2000-06-28 2010-09-14 Glycofi, Inc. Production of galactosylated glycoproteins in lower eukaryotes
WO2002000879A2 (en) 2000-06-28 2002-01-03 Glycofi, Inc. Methods for producing modified glycoproteins
EP1696864B1 (en) 2003-12-24 2014-11-12 GlycoFi, Inc. Methods for eliminating mannosylphosphorylation of glycans in the production of glycoproteins
US7465577B2 (en) 2004-04-29 2008-12-16 Glycofi, Inc. Methods for reducing or eliminating α-mannosidase resistant glycans for the production of glycoproteins
CN101606769A (zh) 2009-07-15 2009-12-23 陈德芳 一种宝石连接结构
AR087433A1 (es) * 2011-08-08 2014-03-26 Merck Sharp & Dohme Analogos de insulina n-glicosilados
WO2013062940A1 (en) 2011-10-28 2013-05-02 Merck Sharp & Dohme Corp. Engineered lower eukaryotic host strains for recombinant protein expression

Also Published As

Publication number Publication date
EP2771461A1 (en) 2014-09-03
EP2771461A4 (en) 2015-06-17
CA2853341A1 (en) 2013-05-02
WO2013062940A1 (en) 2013-05-02
US20140302557A1 (en) 2014-10-09
CN104024409A (zh) 2014-09-03
US9328367B2 (en) 2016-05-03
EP2771461B1 (en) 2019-12-04
JP2014532406A (ja) 2014-12-08
KR20140091018A (ko) 2014-07-18
AU2012329091A1 (en) 2014-05-01

Similar Documents

Publication Publication Date Title
PH12014501427B1 (en) Anti-phf-tau antibodies and their uses
AU2018256629A1 (en) Methods and compositions for consumables
IN2014CN02100A (enrdf_load_stackoverflow)
IN2014CN02963A (enrdf_load_stackoverflow)
IN2014CN03887A (enrdf_load_stackoverflow)
MX2013003681A (es) Ácidos nucleicos manipulados y métodos de uso de los mismos.
PH12013501849A1 (en) Non-aqueous high concentration reduced viscosity suspension formulations of antibodies
MX2012007710A (es) Alfa-amilasas.
MX2015006324A (es) Metodos para la fabricacion de polipeptidos proteoliticamente procesados.
MX2018010572A (es) Inmunoglobulinas heterodimericas.
EP3763810A3 (en) T cell modifying compounds and uses thereof
MX346700B (es) Metodo para mejorar el rendimiento de un polipeptido.
MX2014002053A (es) Anticuerpos anti -mcsp y metodos de uso.
MX2014004871A (es) Composiciones de escoria que comprenden latex y metodos de uso.
GB0917002D0 (en) Improved shigella blebs
MX351565B (es) Colageno 7 y metodos relacionados.
IN2014DN08721A (enrdf_load_stackoverflow)
IN2014CN03072A (enrdf_load_stackoverflow)
SG195114A1 (en) Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
AU2016335217A8 (en) Antigen receptors and uses thereof
PH12013500500A1 (en) Fused heteroaryls and their uses
MX2013004981A (es) Composiciones y metodos para la administracion de agentes terapeuticos.
PH12014500207B1 (en) Biocontrol of nematodes
PH12013500616A1 (en) Antibody compositions and methods of use
MX2014014464A (es) Peptidos penetrantes de celulas y metodos para identificar peptidos penetrantes de celulas.